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Abstract
Chytridiomycosis is an amphibian skin disease that threatens amphibian
biodiversity worldwide. The infectious fungal agent of chytridiomycosis,
Batrachochytrium dendrobatidis, can affect amphibians differently in that some
amphibian populations can co-exist with the fungus and others quickly succumb to
disease. Amphibians in populations that co-exist with the B. dendrobatidis are shown to
have sub-lethal infections on their skins. Several co-existing populations have also been
shown to have higher proportions of individuals with antifungal skin bacteria suggesting
the role of skin bacteria in disease outcome. Little is known about the mechanism(s) that
antifungal skin bacteria use to ameliorate the effects of B. dendrobatidis. In this study I
identified that a B. dendrobatidis isolate JEL 310 zoospores (motile infectious phase)
displays chemotaxis in the presence of two bacterially-produced metabolites (2,4diacetylphloroglucinol and indole-3-carboxaldehyde). In the presence of either
metabolite, B. dendrobatidis (JEL 310) zoospores are more likely to move away from the
metabolites. Another B. dendrobatidis isolate JEL 423 did not display chemotaxis in the
presence of violacein (bacterially-produced metabolite). Using parameters estimated
from my B. dendrobatidis chemotaxis study, a mathematical model illustrates that B.
dendrobatidis JEL 310 zoospores will disperse onto the source containing no metabolite
if zoospores initially start both away from the source and on the source. The model
illustrates that in the presence of a bacterially-produced 2,4-DAPG, B. dendrobatidis JEL
310 zoospores will disperse away from the source. These results suggest that amphibians
that have skin bacteria that produce 2,4-DAPG might be able to keep B. dendrobatidis
infections below the lethal threshold and thus be able to co-exist with the fungus.
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Introduction
Chytridiomycosis is an amphibian skin disease caused by the fungus
Batrachochytrium dendrobatidis (Longcore et al. 1999). The disease causes amphibian
declines and extinctions all over the world (Bosch et al. 2001, Carey et al. 2003, IUCN
2006, Rachowicz et al. 2006, Skerrat et al. 2007). Interestingly, B. dendrobatidis affects
amphibian populations differently even within the same species. There are some
amphibian populations that co-exist with B. dendrobatidis with sub-lethal infections and
other populations (even of the same amphibian species) that decline within 1-2 years to
extinction (Davidson et al. 2003, Hanselmann et al. 2004, Retallick et al. 2004).
Once a single B. dendrobatidis zoospore (the motile infectious phase) infects
amphibian skin, B. dendrobatidis grows exponentially on the skin (Carey et al. 2006).
Carey et al. (2006) suggest the number of B. dendrobatidis needed to cause mortality
must surpass the lethality-threshold. Many amphibian populations that co-exist with B.
dendrobatidis are shown to have small numbers of B. dendrobatidis on frog skins
compared to populations to go extinct. Low numbers of B. dendrobatidis on frog skins
results in sub-lethal infections. One explanation for this may be differences in amphibian
defenses present in populations such as amphibian skin bacteria.
Many bacterial species can be isolated from amphibian skins (Becker et al. 2009,
Harris et al. 2006, Harris et al. 2009a, Harris et al. 2009b, Lam et al. 2010, Lauer et al.
2007, Lauer et al. 2008, Woodhams et al. 2007a, Woodhams et al. 2007b). Some of these
bacteria produce antifungal metabolites that are inhibitory to B. dendrobatidis. There are
three hypothesized mechanisms that amphibian skin bacteria use to reduce the number of
B. dendrobatidis zoospores (its motile pathogenic phase): 1) skin bacteria may reduce the
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number of available attachment sites on amphibian skin, 2) antifungal metabolites
produced by skin bacteria may directly kill B. dendrobatidis, and 3) skin bacteria may
alter B. dendrobatidis zoospore behavior resulting in chemotaxis away from bacteriallyproduced antifungal metabolites. For my thesis research, I have chosen to focus on the
third hypothesis.
The objective of this study was to investigate B. dendrobatidis behavior response
to antifungal metabolites produced by skin bacteria through its movement. Disease
transmission may be a function of behavior movement response of B. dendrobatidis.
Measuring the response of the pathogen in the presence of different concentrations of
antifungal metabolites may allow an improved understanding of the transmission
(infection) and re-infection of B. dendrobatidis. From these measurements I estimated
parameters for a mathematical model used to illustrate how fast a B. dendrobatidis
zoospore will reach an amphibian with bacterially-produced metabolites on its skin. I
also used these estimated parameters to illustrate how zoospores will disperse onto an
amphibian with metabolites present on its skin. Below, I will briefly review emerging
infectious diseases, amphibian declines, chytridiomycosis, and published research about
the amphibian innate immune system that protects against the pathogen.

Emerging Infectious Disease (EIDs)
Over the past two decades there have been a number of emerging infectious
diseases (EIDs), both human and wildlife, that are of concern, and the frequency of
emergence of novel EIDs is increasing (Acevedo-Whitehouse and Duffus 2009, Dazak et
al. 2000). The increased frequency of the emergence of novel EIDs is believed to be a
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result of changes in the environment and human encroachment. Jones et al. (2008)
analyzed the origins of 335 EIDs between the years 1940 and 2004. They found that the
origins of EIDs are significantly correlated with socio-economic, environmental, and
ecological factors. For example, coral bleaching has increased dramatically during the
last few decades. The incidences of coral bleaching are highly correlated with increased
sea-water temperature. At high summer sea-water temperatures, Vibrio shiloi expresses
virulence genes for adhesion. These genes allow the bacterium to displace the normal
microbiota, adhere to the coral mucus, and penetrate the coral epidermis where it
produces toxins that lead to disease (Rosenberg and Ben-Haim 2002).
Emerging infectious diseases pose a threat to global biodiversity. Daszak et al.
(2000) argue that EIDs threaten biodiversity by depopulating host populations and
causing chronic population depression. The geographic spread of chytridiomycosis, an
EID plaguing amphibians worldwide, greatly threatens amphibian biodiversity. Its global
distribution and high virulence as well as other factors influencing amphibian declines are
real concerns for amphibian conservation.

Amphibian Crisis
It has been estimated that at least a third of amphibians worldwide are threatened
with extinction (Briggs et al. 2005, Lips et al. 2008, Moore and Church 2008, Rachowicz
et al. 2006, Stuart et al. 2004) (Figure 1). Amphibian declines and extinction are only a
part of what is being called the sixth mass extinction, which includes other vertebrate and
invertebrate classes (Wake and Vredenburg 2008). The cause of amphibian declines is
hypothesized to be due to a synergy of habitat destruction, exotic predators, competition
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with non-native species, pollution, utilization as food and pets (Blaustein and Wake 1990,
Fisher and Garner 2007, Stuart et al. 2004), effects of climate change (Lips et al. 2008,
Pounds and Crump 1994), increased levels of ultraviolet radiation (Blaustein et al. 1995),
and disease (Carey and Alexander 2003; Pounds and Crump 1994; Pounds et al. 2006).

Although it is argued that deforestation and habitat loss are the major factors in
amphibian declines, Stuart et al. (2004) listed 207 amphibian declines that they reported
as “enigmatic”. These amphibian declines were reported in pristine areas such as natural
parks and areas unaffected by deforestation. Skerratt et al. (2007) demonstrated that the
presence of an EID, chytridiomycosis, is the primary cause of these enigmatic declines.
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Chytridiomycosis has contributed to declines in pristine areas and is responsible for
amphibian extinctions on all continents where amphibians are found (Bosch et al. 2001,
Carey et al. 2003, IUCN 2006, Rachowicz et al. 2006, Skerrat et al. 2007). The major
factors of amphibian declines such as habitat loss and now the emergence of
chytridiomycosis in areas unaffected by habitat loss leave amphibians extremely
susceptible to extinction.

Chytridiomycosis
Chytridiomycosis was first documented in 1998 as the cause of declines of
amphibians in Australia and Central America (Berger et al. 1999). In 1999, Longcore et
al. reported that the agent of chytridiomycosis is a fungus which they named
Batrachochytrium dendrobatidis, a zoosporic chytrid fungus that is the only known
chytrid to parasitise vertebrates; however there are many other species of chytrid that
parasitise plants (Sharma 2004). This pathogen has dimorphic life history: (1) a motile
zoospore stage (the infective phase) and (2) a stationary zoosporangium stage (growing
phase) (Berger et al. 2005a). The fungus has been documented to expand its range as an
advancing wave (Berger et al. 1999, Lips et al. 2005, Lips et al. 2008, Moore and Church
2008).
The emergence of B. dendrobatidis is not well understood and the two opposing
hypotheses that attempt to explain the emergence of this amphibian disease are the novel
pathogen hypothesis and the endemic pathogen hypothesis (Carey and Alexander 2003,
Pounds and Crump 1994, Pounds et al. 2006, Kilpatrick et al. 2010). In support of the
novel pathogen hypothesis is the genetic similarity between isolates of B. dendrobatidis
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found worldwide (James et al. 2009, Morehouse et al. 2003). The little variation found
among isolates from different continents suggest that B. dendrobatidis has been
introduced from a source population into different areas of the world and spread rapidly
throughout. Support for the endemic pathogen hypothesis would entail that the levels of
genetic variation observed from isolates would show more genetic divergence. There is
some evidence that chytridiomycosis outbreaks are correlated with increased
temperatures and thus may contribute to the pathogen becoming endemic. This evidence
provides some support for the endemic pathogen hypothesis, which states that B.
dendrobatidis has been historically endemic and conditions are changing to favor its
pathogenesis. Pounds et al. (2006) correlated outbreaks of chytridiomycosis and global
warming by analyzing the time at which an outbreak occurred and changes in sea surface
and air temperatures. Changes in global temperature may act as a stress mechanism for
amphibians and cause changes in the immune system, making amphibians more
susceptible to disease (Davidson et al. 2007, Raffel et al. 2006) or these changes may
favor the life-cycle of B. dendrobatidis. It is possible the B. dendrobatidis has been
recently introduced into various parts of the world and that changing climatic conditions
facilitates its emergence. Thus, both hypotheses may be correct to some degree.
The infective stage of B. dendrobatidis attacks the keratinized cutaneous layer of
post-metamorphic amphibians and the keratinized jaw sheaths and tooth rows of larvae
(Rachowicz and Vredenburg 2004, Rachowicz et al. 2006). Infection occurs most often
on the ventral surface of the amphibian, but severe infections can spread over the entire
body of the amphibian (Berger et al. 2005a, Pessier et al. 1999). During infection,
hyperkeratosis (an overproduction of keratin in the epidermis) is observed and, in deeper
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regions of the epidermis, hyperplasia (abnormal proliferation of cells) is common and the
epidermis will begin to slough (Berger et al. 1998, Berger et al. 2005a, Longcore et al.
1999). Behavioral changes are often observed in infected individuals such as anorexia,
lethargy, unresponsiveness to stimuli, the inability of the amphibian to right itself (Berger
et al. 2005b, Nichols et al. 2001), and infected individuals are sometimes observed trying
to dry themselves by lifting their limbs into the air or moving away from water sources
(Becker and Harris 2010).
Little is understood about the mode of mortality chytridiomycosis causes, but it is
hypothesized that B. dendrobatidis causes death in two ways: (1) B. dendrobatidis may
release a deadly toxin that diffuses into the blood stream (although to date, none have of
been found), and (2) B. dendrobatidis disrupts osmotic and ionic balances of the
amphibian due to hyperkeratosis and hyperplasia (Berger et al. 1998, Berger et al. 2005a,
Carey et al. 2003, Voyles et al. 2007, Voyles et al. 2009). Disruption of osmotic and
ionic balances has been documented to cause cardiac distress and failure in postmetamorphic amphibians (Voyles et al. 2009). Mortality is documented primarily in
post-metamorphic amphibians, but can also occur in larvae (Blaustein et al. 2005).
A single zoospore has the capability of establishing infection due to exponential
growth of the pathogen observed on amphibian skin. Carey et al. (2006) show that one
zoospore was able to cause morbidity and mortality in the boreal toad, Bufo boreas.
When a single zoospore comes in contact with an amphibian it begins to form a
zoosporangium and produces more zoospores within the zoosporangium that are later
released. These released zoospores have the capability to re-infect the amphibian or be
transmitted to a new host (Rachowicz et al. 2006). Carey et al. (2006) also demonstrated
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that B. dendrobatidis zoospore numbers on toad skins had to surpass a threshold of 107108 zoosporangia per toad in order to cause mortality of B. boreas.
Moss et al. (2008) recently found that during the motile zoospore stage, B.
dendrobatidis displays chemotactic ability to respond with positive movement towards
hydrolyzed casein (known to support B. dendrobatidis growth), gelatin hydrolysate (a
constituent of the culture media used for B. dendrobatidis), and cysteine (an abundant
amino acid of keratin found in epidermal cells of amphibian skin). Their findings suggest
that the pathogen is capable of responding to keratin in amphibian skin and can use
chemotaxis as a method to detect the amphibian host. Once a single zoospore detects and
comes in contact with a susceptible amphibian host, exponential growth can quickly
surpass a lethality-threshold resulting in mortality.
What is very intriguing about this disease is that not all amphibian species decline
to extinction and some species are able to co-exist with the fungal pathogen (Davidson et
al. 2003, Hanselmann et al. 2004, Retallick et al. 2004). Even more intriguing is that the
same is true within some amphibian species, where some populations are able to co-exist
and other populations of the same species drastically decline to extinction. For example,
Rana sierrae, the mountain yellow-legged frog of the Sierra Nevada Mountains in
California, USA has some populations of R. sierrae that have been co-existing with B.
dendrobatidis for >6 years and other populations that go extinct within 1-2 years after the
pathogen first emerges (Lam et al. 2010, Rollin-Smith et al. 2006, Woodhams et al.
2007b). A better understanding of differences between populations that co-exist with the
pathogen and populations that go extinct due to the pathogen such as differences in
amphibian defenses is strongly needed. Differences in amphibian defenses may lead to
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insights into finding a more environmentally friendly way to stop the spread of the
disease and allow for the re-introduction of captive frogs from survival assurance
colonies.

Amphibian Defenses Against Chytridiomycosis
There is considerable variation in amphibian species’ and populations’ response
to chytridiomycosis (Lips et al. 2005); this may be due to variation in the virulence of B.
dendrobatidis isolates (Berger et al. 2005b, Retallick and Miera 2007), although
preliminary data show that there is little genomic variation among B. dendrobatidis
isolates sampled (James et al. 2009, Morehouse et al. 2003). Another source of variation
may be differences in the types and magnitude of immune defenses the amphibian is able
to mount against the pathogen.
There are two major components of the immune system: (1) the adaptive immune
system and (2) the innate immune system. Although it has been found that amphibians
do elicit an adaptive immune response to B. dendrobatidis by producing antibodies, there
is no published evidence that this response produces protection or immunity (Berger et al.
2002). A possible explanation for the inadequacy of the adaptive immune response is
that the response is “too little, too late”. The response does not occur in time to prevent
the mortality from the disease. Another possibility is that the antibodies are inadequately
delivered to the infection due to thickened epidermis. A third possibility is that B.
dendrobatidis is turning off the amphibians’ immune system. Recent work shows that
infected amphibians’ adaptive immune system loci are either not up regulated or are
down regulated (Rosenblum et al. 2009).
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The innate immune system is the first line of defense against B. dendrobatidis and
has several components that are capable of providing protection for the amphibian. There
are three known components of the innate immune system that may give amphibians
protection from B. dendrobatidis: (1) the epidermis as a barrier, (2) antimicrobial
peptides the amphibian produces, and (3) antifungal symbiotic bacteria that lives on
amphibian skin (although some researchers may be uncomfortable calling symbiotic
bacteria part of the innate immune system).
Research to investigate how the epidermis as a barrier may protect against
chytridiomycosis has not been explored. It is possible that amphibians with thick
epidermal layers may have better protection against the pathogen. Also, variation in the
components of mucus secretions and differences in the thickness of the mucus layer may
also provide explanations for the varying degree of susceptibility in different amphibian
species to the B. dendrobatidis. Mucus can protect amphibians from both bacterial and
fungal pathogens (Fontana et al. 2006). Fontana et al. (2006) describe a new gland
named mucus-producing granular glands (MPGGs) that produce mucus in specialized
granular glands. MPGGs produce acidic mucus relative to neutral mucus produced in
mucous glands. They hypothesize that neutral and acidic mucus may form two layers of
mucus that consists of a thin, watery neutral mucus layer with a thicker acidic layer
underneath. More research would be necessary to understand how the epidermis as a
barrier and the mucus layer are involved in the susceptibility of amphibians to
chytridiomycosis.
Antimicrobial peptides (AMPs) are the best studied of the three components of
the amphibian innate immune system (Davidson et al. 2007, Rollins-Smith et al. 2002,
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Woodhams et al. 2007a). These peptides are produced and stored in granular glands in
the dermis of amphibian skin and found predominately on the dorsal surface of the
amphibian. They are released in response to stimulation from the sympathetic nervous
system (Mills and Prum 1984). AMPs have been documented as having inhibitory
activity against bacteria, viruses, including HIV (VanCompernolle et al. 2005), protozoa,
and fungi (Rinaldi 2002, Zasloff 2002). Many of these peptides have shown inhibitory
activity in vitro against B. dendrobatidis (Davidson et al. 2007, Rollins-Smith et al. 2002,
Rollins-Smith et al. 2005, Rollins-Smith et al. 2006). Amiche et al. (1999) suggest that
each species has a unique set of AMPs. Among individuals, these peptides may vary in
the density and concentration in which they occur on amphibian skin and the variety of
AMPs present at any given time (Tennessen et al. 2009). Woodhams et al. (2007a)
performed laboratory experiments with four Australian amphibian species in which
survival rate in vivo and, in a separate experiment, the in vitro effectiveness of the AMPs
produced by each species were studied. They experimentally infected the frogs with the
pathogen and observed survival rate. The more effective the species’ AMPs were against
B. dendrobatidis in vitro, the higher the species’ survival rate. However, factors such as
environmental change, pesticides, and continual exposure to the pathogen may minimize
the effectiveness of AMPs produced by amphibians (Davidson et al. 2007, Rollins-Smith
et al. 2002, Rollins-Smith et al. 2006). These factors may influence the production of
AMPs as well their depletion. For example, pesticides may block chemical signals that
result in the amphibian’s capabilities to produce a particular AMP although no evidence
of this exists in the literature.
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A less studied component of the innate immune system is the symbiotic bacteria
that reside on amphibian skin. Amphibian skin provides a seemingly ideal habitat for
microorganism colonization in that it is moist and nutrient-rich (Guirard and Snell 1962).
Bettin and Greven (1986) demonstrated that amphibian skin is colonized by bacteria and
by their presence suggest that these bacteria are somewhat resistant to the antimicrobial
peptides the amphibian produced. Their discovery suggests that some species of bacteria
may have co-evolved to be resistant to the AMPs found on the amphibian species they
inhabit.
Relationships between commensal bacteria and eukaryotic organisms often occur
in nature and often these bacteria protect their hosts from pathogens. Symbiotic bacteria
that protect organisms from fungi have been identified in Caribbean shrimp, Palaemon
macrodactylus (Gil-Turnes et al. 1989), pea aphids, Acyrthosiphon pisum (Scarborouch et
al. 2005), the four-toed salamander, Hemidactylium scutatum (Banning et al. 2008, Lauer
et al. 2008), the eastern red back salamander, Plethodon cinereus (Becker et al. 2009,
Harris et al. 2006, Harris et al. 2009b, Lauer et al. 2007, Lauer et al. 2008) and the
mountain yellow-legged frog, Rana sierrae (Lam et al. 2010, Harris et al. 2009a,
Woodhams 2007b).
In 2006, Harris et al. identified 10 genera of bacteria isolated from the skins of the
eastern red-backed salamander, Plethodon cinereus, and the four-toed salamander,
Hemidactylium scutatum, that displayed antifungal activity against B. dendrobatidis in
vitro. They first isolated bacteria from the salamander skins and then challenged the
bacteria against B. dendrobatidis in vitro. They discovered that some of the bacteria
produced a zone of inhibition around the pathogen suggesting antifungal activity.
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More recently, it has been found in field surveys that populations of Rana sierrae
that co-exist with B. dendrobatidis have higher proportions of individuals with anti-B.
dendrobatidis skin bacteria than populations that are found to go extinct due to the
pathogen (Lam et al. 2010, Woodhams et al. 2007b). In the initial field study,
Woodhams et al. (2007b) show that a population where B. dendrobatidis had recently
emerged and that was predicted to go extinct (due to the history of populations in the
same area) had a low proportion of individuals with at least one anti-B. dendrobatidis
skin bacterial species relative to another population persisting with B. dendrobatidis. The
population with a low proportion of individuals with protective skin bacteria went extinct
the following year. An extension of the Woodhams et al. (2007b) field study shows that
a R. sierrae population with a higher proportion of individuals with anti-B. dendrobatidis
bacteria survived the arrival of B. dendrobatidis even though it was in an area where
historically all populations declined to extinction after the emergence of the pathogen.
Lam et al. (2010) performed a field survey on a R. sierrae population before the
emergence of the pathogen. This population was predicted to go extinct due to historical
field surveys where all populations in the same geographical field location became
extinct 1-2 years after the arrival of B. dendrobatidis (Vance Vredenburg, personal
communication). The pathogen emerged in this population a year after the initial field
survey, and two years later the population is still found to be surviving and endemic with
B. dendrobatidis. These field surveys suggest a threshold proportion of individuals need
anti-B. dendrobatidis bacteria in order for the population to co-exist with the fungus
(Figure 2). This is analogous to herd immunity in which only a proportion of the herd or
population needs to be immunized in order to establish protection from a pathogen for the
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entire population (Gonclaves 2008). These studies suggest that approximately 80% of
individuals need to have anti-B. dendrobatidis protective skin bacteria for co-existence
with B. dendrobatidis to occur and suggests that the basic reproductive number, Ro, of B.
dendrobatidis is less than 5 (Lam et al. 2010). These studies suggest that future
bioaugmentation treatment would only need to include a proportion of the population
instead of the whole population.
These field studies are consistent with the hypothesis that populations with higher
proportions of individuals with anti-B. dendrobatidis bacteria can co-exist with the
fungus. Although the survival of populations with a high percentage of individuals with
anti-B. dendrobatidis does not prove the hypothesis, it does strengthen it and indicates
that more research is merited. Another interesting result from these R. sierrae field
surveys is that the populations that co-exist do so with a significantly lower density of B.
dendrobatidis zoospores on their skins than the populations that went extinct (Woodhams
et al. 2007b) (Figure 3). This also suggests that there may be a threshold of zoospores
needed to cause mortality of the amphibian (Carey et al. 2006) and that populations that
co-exist with B. dendrobatidis do so with sub-lethal infections. The higher proportion of
individuals with anti-B. dendrobatidis bacteria correlated with individuals that have sublethal infections suggests that skin bacteria plays a role in driving B. dendrobatidis
densities down and below lethality-threshold.
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Several anti-B. dendrobatidis bacterial isolates have been found to produce
antifungal metabolites that are capable of inhibiting B. dendrobatidis in vitro (Brucker et
al. 2008a, Brucker et al. 2008b). Harris et al. (2009b) show that the addition of
Pseudomonas reactants, a previously identified bacterium found to inhibit B.
dendrobatidis, to the eastern red-backed salamander, Plethodon cinereus, ameliorated the
effects of chytridiomycosis. The salamanders that were bathed with and colonized by P.
reactants lost less weight, a symptom of chytridiomycosis, than salamanders exposed
only to B. dendrobatidis. Harris et al. (2009a) also show that the addition of
Janthinobacterium lividum, another bacterium found to be anti-B. dendrobatidis, to Rana
sierrae juveniles prevented the colonization of B. dendrobatidis and had lasting positive
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effects for 140 days. The frogs that were bathed in and colonized with J. lividum were
also found to have violacein, an antifungal metabolite produced by J. lividum (Brucker et
al. 2008b), on their skins, suggesting that bio-augmentation of J. lividum increased
violacein concentration on the skins of R. sierrae. These studies, in conjunction with
field surveys, strongly suggest that bio-augmenting a population to have a higher
proportion of individuals with anti-B. dendrobatidis skin bacteria may be a feasible tool
to controlling the pathogen in wildlife. If there is a threshold proportion of individuals
needed to protect the entire population, not all of the individuals would need to be treated
(this is analogous to herd-immunity).
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Understanding the Relationship Between B. dendrobatidis and the Innate Immune
System by Modeling
The conservation implications for using anti-B. dendrobatidis bacteria in nature
need to be further researched. For example, interactions of symbiotic bacteria and AMPs
are likely to influence the success of the application of anti-B. dendrobatidis skin bacteria
to an amphibian population that may result in the protection from the pathogen.
However, field studies and experiments to study the interactions of these components of
the innate immune system and the pathogen may be complicated and costly to study in
vivo. There are many uncontrollable interactions that may complicate designing a plan to
conserve amphibian species. Mathematically modeling this dynamic system is one
feasible method to further studying this system.
Two recent mathematical models of B. dendrobatidis and its host have been
unable to predict co-existence between amphibians and B. dendrobatidis despite using a
variety of parameter values (Briggs et al. 2005, Mitchell 2008). The Briggs et al. (2005)
model could not explain the differences between populations of R. sierrae co-existing
with B. dendrobatidis and those that declined to extinction by differences in transmission
rate of B. dendrobatidis, susceptibility, infectiousness, or population size. Their model
only predicted one of two outcomes; there was either extinction of the amphibian host or
extinction of the pathogen. One criticism of this model and possible explanation for the
models inability to predict co-existence may be the lack of a re-infection parameter,
which is the proportion of B. dendrobatidis zoospores that re-infects its host. The model
proposed by Mitchell et al. (2008) model could only predict the co-existence of the toad,
Bufo bufo, if the model incorporated saprobic reproduction of B. dendrobatidis (which

18
has not been observed) for a few B. bufo generations. However, eventually B. bufo went
extinct as B. dendrobatidis density increased. This model also does not include a reinfection parameter, but assumes that all juvenile toads that were infected with the fungus
left the population and died.
A re-infection parameter of the amphibian host is needed to reflect the biology of
B. dendrobatidis. As mentioned earlier, B. dendrobatidis has the capability to re-infect
its host and, thus, causes exponential growth of zoospores on amphibian skin. However,
Woodhams et al. (2007b) found that populations of R. sierrae that were co-existing with
B. dendrobatidis had significantly lower averages of zoospores on frog skins and that
these populations had higher proportions of individuals with anti-B. dendrobatidis skin
bacteria. This suggests that the role of amphibian defenses is to lower the re-infection
parameter of B. dendrobatidis and control the growth of zoospores on amphibian skins
which may result in co-existence of the amphibian and fungus.

Study System
For my thesis I have investigated the motile zoospore life-stage of B.
dendrobatidis in the presence and absence of metabolites produced by known amphibian
skin bacteria to further investigate the role of these metabolites in transmission (infection)
and re-infection. As proposed by Moss et al (2008), B. dendrobatidis posses chemotaxis
in the presence of constituents of its food source. I have expanded this idea to investigate
if B. dendrobatidis is also chemotactic in the presence of metabolites that display anti-B.
dendrobatidis properties. Although known concentrations of bacterially-produced
metabolites on amphibian skin are poorly estimated due to small sample size and few
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species studied, it is hypothesized that concentrations are most likely variable and
unevenly dispersed on amphibian skin. This is due to the idea that some
microenvironments (Figure 4A-D) on amphibian skin would attract high concentrations
of bacterial growth (such as mucus glands) and other microenvironments would attract
low concentrations of bacterial growth (such as granular glands that produce AMPs
active against bacteria).

Figure 4. Three different types of microenvironments (A-C) found on amphibian skin that
would determine different amounts and composition of bacterial growth. The mucus gland
(A) is surrounded by a thicker mucus layer and has several different bacteria species
surrounding the gland. The granular gland (B) is distinguished from the mucus gland by a
gradient of AMPs (shown in red) and would only attract bacteria species that are AMP
tolerant. Small pores (C) along the epidermis would attract different bacteria and possibly
create anaerobic environments. Bacteria are shown to inhabit both the surface layer of the
epidermis as well as in the mucus layer itself. An illustration with all three
microenvironments is shown by D.
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To study chemotaxis of B. dendrobatidis zoospores, I followed individual
zoospore movement away and towards metabolites produced by amphibian skin bacteria.

Metabolites Produced by Anti-B. dendrobatidis Skin Bacteria
I investigated three metabolites produced by known amphibian skin bacteria that
show inhibitory activity against B. dendrobatidis. These three metabolites were chosen
based on their known anti-B. dendrobatidis properties and availability. These
metabolites have all been identified from skin bacteria isolated from amphibian skins.

The metabolite 2,4-diacetylphloroglucinol (2,4-DAPG) has antiviral, antibacterial,
antifungal, antihelminthic, and phytotoxic properties (Weller et al. 2007) (Figure 5). This
metabolite has been identified in several species of Pseudomonas and is a known
protector against many root and seedling diseases (Weller et al. 2007). It was first shown
to have anti-B. dendrobatidis properties when identified from Lysobacter gummosus
isolated from the skins of amphibians (Brucker et al. 2008a). The anti-B. dendrobatidis
bacterium has been identified on the eastern red-backed salamander, Plethodon cinereus,
and the four-toed salamander, Hemidactylium scutatum (Harris et al. 2006). Using a 96well inhibitory growth assay, Brucker et al. (2008a) determined that 2,4-DAPG has
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inhibitory properties against B. dendrobatidis (IC50=8.73µM, MIC=136.13µM) although
the mechanisms of this inhibition are unknown.
Two other anti-B. dendrobatidis metabolites identified from amphibian skin
bacteria used during this experiment are indole-3-carboxaldehyde (I3C) and violacein
(Figure 5). These metabolites were identified from the bacterium Janthinobacterium
lividum (Brucker et al. 2008b) that has been cultured from the skins of the salamander P.
cinereus (Harris et al. 2006) and from the skins of the frogs Rana muscosa (Woodhams et
al. 2007b) and Rana sierrae (Lam et al. 2010). The metabolite I3C is more commonly
known as a hydrolysis product found in the plant family Cruciferae and for its antitumorgenesis properties (Anderton et al. 2004, Chohan et al. 2010), but has also been
identified in several bacteria species (Brucker et al. 2008b, Gutierrez-Lugo et al. 2005).
I3C was also shown to be inhibitory against B. dendrobatidis using 96-well inhibition
assays (IC50= 0.13µM; MIC=68.9µM) (Brucker et al. 2008b). Brucker et al. (2008b)
found on one wild caught P. cinereus a I3C concentration of 51µM, but a larger sample
size is needed to confirm I3C concentration on amphibian skin. Violacein is a dark violet
pigment that was first identified to be produced by Chromobacterium violaceum (Liu and
Nizet 2009), which is a close relative to J. lividum. It has been shown to have strong
antioxidant properties and has the capacity to induce apoptosis (Liu and Nizet 2009).
Violacein has been identified with antifungal (Becker et al. 2009, Brucker et al. 2008b),
antibacterial, antiprotozoan (Liu and Nizet 2009), antiviral, and antitumorgenesis
(Antonisamy and Ignacimuthu 2010). Brucker et al. (2008b) identified that violacein was
inhibitory against B. dendrobatidis using a 96-well inhibition assay (MIC=1.8µM). They
also identified that there appears to be a threshold concentration of violacein needed to
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inhibit B. dendrobatidis in vitro. Becker et al. (2009) determined that the concentration
of violacein on the skins of P. cinereus that was protective against B. dendrobatidis was
approximately 18µM and Brucker et al. (2008b) found concentrations of violacein on
three naturally caught P. cinereus to be 207µM, 10µM, and 4µM respectively.
For this study I used these three metabolites at inhibitory concentration of 50%
(IC50) and minimum inhibitory concentration (MIC) with the exception of violacein.
Since there was no identified IC50 with violacein, I used the concentration of violacein
found to be protective against B. dendrobatidis determined on the salamander P.
cinereus. Natural concentrations of these metabolites found on amphibian skins needs to
be researched more with larger sample sizes and with more than one amphibian species.

The Role of Chemotaxis of B. dendrobatidis in its Transmission and Re-Infection
To investigate how chemotaxis can influence transmission and re-infection of B.
dendrobatidis, I mathematically illustrated zoospore movement using a random walk on a
simple lattice with parameters gathered from my three metabolite investigations. With
this model I illustrate that if a zoospore is in water near an amphibian is it more likely
that the zoospore will move towards the amphibian (initial infection) or away
(transmission) depending on the metabolite concentration present on the amphibian.
Likewise, I illustrate that a zoospore on the amphibian skin is more likely to move
towards the amphibian (re-infection) or away from that amphibian to infect a susceptible
host (transmission) dependant on metabolite concentration present on the already infected
amphibian.
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This model can be important in understanding the lethality-threshold of B.
dendrobatidis and can provide insights in developing mathematical models that include
re-infection parameters as well as varying proportions of populations that have anti-B.
dendrobatidis bacteria on amphibian skins. If metabolite concentrations on amphibian
skins are high they may provide the amphibian with protection from B. dendrobatidis by
encouraging zoospores to move away and not colonize. This may lead to zoospores
moving towards amphibians without anti-B. dendrobatidis bacteria. This could quickly
cause mortality of susceptible amphibians if a large number of zoospores move towards it
and if zoospore density surpasses the lethality-threshold (Carey et al. 2006). Likewise
this model may also predict that if metabolite concentrations are present on the
amphibian but not high enough to provide complete protection from B. dendrobatidis
through mortality of the pathogen, then it may be possible to maintain B. dendrobatidis
infections below mortality threshold resulting in the endemic populations of amphibians.

Methods
Maintaining Batrachochytrium dendrobatidis Cultures
Two isolates of B. dendrobatidis, JEL 310 and JEL 423, used for this project were
received from Dr. Joyce Longcore at the University of Maine. Isolate JEL 310 was
isolated from the frog species Smilisca phaeota from Fortuna, Panama by P. Murphy and
had been cultured from -80oC frozen stock for approximately a year before the beginning
of this experiment. The isolate JEL 310 has been shown to have morbidity and mortality
effects on Plethodon cinereus (Becker et al. 2009). The isolate JEL 423 was isolated
from the frog species Phyllomedusa lemur that was collected during a die-off in Panama
and had been cultured from -80oC frozen stock approximately one month before the
beginning of its use.
Stock cultures were serially transferred on a weekly basis for both JEL 310 and
JEL 423. Both isolates of B. dendrobatidis were maintained in 1% tryptone broth and
stored at 23oC. Each week 1mL of culture was transferred to a fresh stock of tryptone
broth.
Additional stock cultures containing antibiotics were serially transferred on a
monthly schedule. Both isolates of B. dendrobatidis were maintained in 1% tryptone
broth + 50µL of penicillin (100mg/mL) and streptomycin sulfate (200mg/mL) each.
Cultures were allotted a week of growth at 23oC and then stored at 4oC for approximately
a month. Each month 1mL of the culture was transferred to fresh antibiotic broth. These
cultures were maintained in the event that stock cultures maintained on a weekly basis in
the absence of antibiotics were compromised. In the event new weekly cultures were
needed, 1mL of the monthly stock that contained antibiotics was transferred to fresh 1%
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tryptone broth and allowed to grow one week before another transfer to 1% tryptone
broth. After two serial transfers into fresh 1% tryptone, isolates were then used for
experimentation to ensure that there were no effects from being maintained in antibiotics.

Harvesting B. dendrobatidis Zoospores
In order to harvest B. dendrobatidis zoospores, 1mL of weekly B. dendrobatidis
stock was transferred to a 1% agar + 1% tryptone plate and evenly spread on the entire
surface of the plate. Plates were allotted time to just dry (approximately 5-10 minutes),
covered and sealed, and placed at 23oC for approximately 3-5 days. After 3-5 days of
growth, plates were observed under a compound microscope at 200x to confer active
zoospores.
Plates that had activity were then flooded with 3mL of sterile Provosoli medium
(Wyngaard and Chinnappa, 1982) for 20 minutes to stimulate B. dendrobatidis
zoosporangia to release zoospores. Another 1mL of Provosoli medium was added to the
plates and gently “swished” around the plate to bath the zoosporangium. All standing
liquid containing the released zoospores was then gently removed off of the plate using a
pipette and stored in 15mL Falcon tubes.
Active zoospores, defined as actively moving, were then counted using a standard
hemocytometer slide. To reach target densities of approximately 450-500 active
zoospores/100µL Provosoli medium, active zoospore broths were either concentrated or
diluted accordingly.
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Customized Microscope Slides
Standard glass microscopes slides were fashioned with eight 1cm x 1cm chambers
using 100% Silicone Aquarium Sealant (All-Glass Aquarium Co., Inc., Franklin, WI)
(Figure 6). These chambers were made by hand using a standard grid. The silicone was
given at least 12 hours to set while in a sterile, closed container.

Figure 6. Customized microscope slide with 8
chambers approximately 1cm x 1 cm made out
of 100% Silicone Aquarium Sealant.

Immediately before an experiment 40µL of substrate was plated along the left
edge of each chamber. The experimental treatments were: 1% agar + 1% tryptone
(control) and 1% agar + 1% tryptone with one of the following: 68.89µL indole-3carboxaldehyde (I3C) (minimum inhibitory concentration (MIC)), 136.13µL 2,4diacetylphloroglucinol (2,4,-DAPG), which is the MIC (2,4-DAPG high), 8.73µL 2,4DAPG, which is the IC50 (2,4-DAPG low), 1.8µL violacein, which is the MIC
(violacein low), and 18µL violacein (violacein high) (Table 1). For all metabolites with
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the exception of violacein the B. dendrobatidis isolate JEL 310 was studied. The change
in isolate use was due to the mortality of isolate JEL 310 and the exhaustion of available
replacements. The B. dendrobatidis isolate JEL 423 was used to study chemotaxis in the
presence and absence of violacein. Substrates were given a few minutes to polymerize
before a solution of 450-500 active zoospores of B. dendrobatidis per 100µL Provosoli
medium was added to a chamber. Vaseline was added around the silicone chambers to
ensure there was sealing between all chambers and a 24 x 60 mm plastic microscope
cover slip was used to seal top of chambers.
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Data Collection of Zoospore Movement
Chambers were observed at two times: initial time (t = 0) and 6 hours at 200x
using a Nikon eclipse TE2000 inverted microscope. Sampling time was determined by
calculating the proportion of B. dendrobatidis zoospores that were still active every hour
for 12 hours. This was done by randomly sampling ten 100µm x 100µm grids using a
random number generator and calculating the average proportion of active zoospores for
each hour. Sampling time was determined to be initial time (t = 0) and the time where
approximately 50% of B. dendrobatidis isolate 310 zoospores remained active. The
substrate was sometimes placed to appear on the left and other times to appear on the
right to account for any effects due to light. Data were collected by taking 50 still-frame
photos over a 10 second period (approximately every 0.2 seconds) taken with a Roper
Scientific CoolSnap HQ monochrome digital camera focused at the center width of the
chambers at approximately the center depth along the edge of the substrate and of interest
area (Figure 7). These images were collected using Roper Scientific Image Capture
Software (Roper Scientific, Germany).
Zoospore movement was collected by haphazardly selecting 5 zoospores from
each of the three distances away from the edge of the substrate at both t = 0 hours and t =
6 hours. The distances used were 0-100µm, 200-300µm, and 500-600µm. To put this in
context, the far end of the silicone was 5000µm. Each selected zoospore was followed
throughout each still-frame for 10 seconds. At each transition between still-frames,
which was approximately every 0.2 seconds, the movement of the zoospore either
towards the substrate, no movement, or away from the substrate was recorded.
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Initial distance of the zoospore to the edge of the agar source (agar/Provosoli
interface) was also recorded. After collecting movement data, end point distance of the
zoospore to the edge of the agar source was also recorded. Total distance moved by a
zoospore over 10 seconds was calculated.

Figure 7. A schematic of the 3D area within a chamber that was used for sampling B.
dendrobatidis zoospore movement. The camera was focused in the center of the
substrate at central depth along the edge of the substrate and area where suspended
zoospores were plated. The 3D box in the figure represents the substrate.

The number of active zoospores was counted at both 0-100µm and 500-600µm
distances away from the substrate and compared between t = 0 hours and t = 6 hours.
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Statistics
Zoospore movement data were statistically analyzed to determine if moment
towards substrate and away from substrate was a function of time, location, and treatment
using ANOVA. The number of movements made towards and away from the substrate
was analyzed only. The no movement variable was not analyzed since it was determined
by the other two variables. Each data point used for statistical analysis was an average of
all zoospores recorded within a time, location and treatment combination. The averaging
procedure eliminated the possibility of “pseudo-replication” because the responses of
potentially interacting zoospores within a chamber were averaged. This left the level of
replication as five, which was the number of chambers used for each treatment. In
addition, according to the central limit theorem those means should approach a normal
distribution. If time and location were found to not have a significant effect on
movement towards substrate and away from substrate, they were pooled together and
tested using a one-way ANOVA to determine the effect of treatment.
The number of active zoospores at two locations (0-100um and 500-600um) and
at two time points (t = 0 and 6 hours) were compared using ANOVA. If location had no
effect on the number of active zoospores then these data were pooled.
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Mathematical Model

A random walk on a simple lattice was modeled with a system of difference
equations describing B. dendrobatidis zoospore movement away from or towards a
source (S) depending on its starting distance from the source. The source represents the
1% agar + 1% tryptone (control) or 1% agar + 1% tryptone + metabolite (experimental).
The following nine boxes represent an increasing distance away from the source (S).
Since we will later find location was found to have no effect on zoospore movement, the
probability of a zoospore moves to the left (ρL) or to the right (ρR) during the time
increment of 10 seconds are the same no matter what location the zoospore is in. A
schematic of the model is shown in Figure 8 and a full set of equations is given as
follows:
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The model was implemented stochastically to illustrate how many steps a single
zoospore would take to reach the source. A direct simulation was created to simulate
zoospores moving on a lattice in order to measure the number of steps a zoospore took to
reach the source. This model was simulated 500 times once for each treatment with one
zoospore at starting position farthest away from the source using a probability matrix.
The mathematical equations (1.1-1.10) describe the probability for a single zoospore to
be at a certain location after t time steps. Simulations then describe a zoospores random
movement along the lattice using the described probabilities given by equations 1.1-1.10.
The number of movements it took for a zoospore to reach the source was recorded and
the weighted average for each treatment was found.
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The model was also implemented deterministically to illustrate the dispersal of
zoospores if their starting position is at the middle of the model (D5). The overall
distribution was then tracked as a function of time and recorded. This model was
performed for each treatment once with 200 zoospores beginning at D5. The model was
stopped at six different time steps: initial time step where all 200 zoospores start at D5
and every 10 time steps until 50 times steps are reached. The number of zoospores at
each position was recorded and the weighted average for each treatment was found.
The mathematical software Sage® (www.sagemath.org) was used to implement
all models. Zoospores with a starting position farthest away from the source would
correspond to zoospores at a mucus/pond interface and would simulate zoospores that
would be transmitted from either pond water or from an infected amphibian. Zoospores
starting on the source (S) would be similar to zoospores released to the surface of the
epidermis that could re-infect.

Parameter Estimation
Parameters are fully defined with estimated values from my experiment in Table
2. Each parameter was estimated by finding the probability of a zoospore moving
towards or away from the source. Since location was found to not have an effect on
zoospore movement, the probabilities for a zoospore moving from each box either
towards or away from the source is the equal for all distances.
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Results
Description of Batrachochytrium dendrobatidis Zoospore Movement Patterns
Both isolates of B. dendrobatidis, JEL 310 and JEL 423, displayed several
patterns of zoospore movement (Figure 9A-D). These movement patterns were observed
in all treatments including the control, and there were no distinguishing movement
patterns that were typical to an experimental treatment. Zoospores typically were seen to
move in circular patterns (Figure 9A) or were seen oscillating inwards or outwards
(Figure 9B). Less often, zoospores were seen to display linear movement either with
direction (Figure 9C) or without direction (Figure 9D) in a seemingly random nature.
Linear non-directional movement was observed to be the most rare pattern of zoospore
movement.
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Figure 9. These are movement patterns observed by B. dendrobatidis
zoospores (JEL 310 and 423) in all treatments including the control.
Patterns most frequently observed were circular (A) and inward/outward
oscillations (B). Less commonly, zoospores were also seen to move
linearly with direction (C) or without direction (D).

Determining Sampling Times
Sampling times were determined to be initial time (t = 0) and the time at which
50% of B. dendrobatidis zoospores remained active for isolate JEL 310 (Figure 10A) (n =
3). This isolate chosen was initially to be used for the entire experiment. Approximately
50% of zoospores remained active up to 6 hours after harvest and by the twelfth hour the
vast majority of zoospores were no longer active. When observed at 24 hours,
zoosporangium could be seen suggesting that inactive zoospores were not dead but
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transition life stage. Activity was also measured for isolate JEL 423 (Figure 10B) where
by the twelfth hour approximately 75% of zoospores remained active (n = 3).

Figure 10. Zoospore activity for B. dendrobatidis isolates JEL 310 (A) (n = 3)
and JEL 423 (B) (n = 3). Sampling times were determined to be initial (t = 0) and
where 50% of JEL 310 zoospores remained active (~t = 6).

Synopsis of Results
Zoospores from isolate JEL 310 moved toward the source less in both 2,4-DAPG
low and 2,4-DAPG high treatments than the control treatment, but not the I3C treatment.
For all treatments (2,4-DAPG low, 2,4-DAPG high, and I3C), zoospores from isolate JEL
310 moved away from the metabolite more than the control treatment. The mathematical
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models predicted that zoospores would reach the source in the control treatment faster
than zoospores in 2,4-DAPG low, 2,4-DAPG high, and I3C treatments and that more
zoospores would distribute onto the source in the control than all three treatments.
There was no difference in the number of movements zoospores from isolate JEL
423 made either toward or away from both violacein low and violacein high compared to
the control treatment. The mathematical models predicted that zoospores in the control,
violacein low, and violacein high would all reach the source at approximately the same
time and that zoospores would distribute equally in the violacein high and control
treatment. Less zoospores would distribute on the source in the violacein low treatment
compared to violacein high and control treatments.

B. dendrobatidis (JEL 310) Zoospore Movement Toward and Away from the Source

Within treatment comparisons
There was no overall significant effect of time (t = 0 hours versus t = 6 hours) on
zoospore movement patterns and total distance a zoospore moved towards or away from
the source during a 10 second time period within any of the treatments (Table 3). Time
had no effect on zoospore movement towards the source within the control, 2,4-DAPG
low, 2,4-DAPG high, and I3C treatments (Table 3). Time had no effect on zoospore
movement away from the source within the control, 2,4-DAPG low, 2,4-DAPG high, and
I3C treatments (Table 3). Time also had no effect on total distance a zoospore moved
during a ten second period of time within the control, 2,4-DAPG low, 2,4-DAPG high,
and I3C treatments (Table 3). Since there was no effect of time on zoospore movement
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either towards or away from the source or on total distance a zoospore moved these data
were pooled together.

Table 3. The effect of time on B. dendrobatidis (JEL 310) movement within treatment
comparisons towards and away from the source and total distance a zoospore moved
within a time period.
ANOVA
Movement towards the source
Treatment

n’s

df

F

Sig.

Control

10

28

0.24

0.0639

2,4-DAPG low

10

28

0.02

0.8994

2,4-DAPG high

10

28

0.82

0.3731

I3C

6

18

0.10

0.7206

Movement away from the source
Treatment

n’s

df

F

Sig.

Control

10

28

3.77

0.1262

2,4-DAPG low

10

28

0.47

0.4943

2,4-DAPG high

10

28

0.03

0.8573

I3C

6

18

0.10

0.7590

Total distance a zoospore moved during a 10 sec. period
Treatment

n’s

df

F

Sig.

Control

10

28

0.24

0.6302

2,4-DAPG low

10

28

3.08

0.7223

2,4-DAPG high

10

28

0.53

0.4733

I3C

6

18

1.79

0.9516
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Location (0-100µm, 200-300µm, and 500-600µm) had no effect on zoospore
movement towards the source within the control, 2,4-DAPG low, and I3C treatments
(Table 4). Zoospores moved more towards the metabolite as location from the source
increased within the 2,4-DAPG high treatment (P = 0.0025) (Table 4) (Figure 11A).
Location had no effect on zoospore movement away from the source within the
control, 2,4-DAPG low, and I3C treatments (Table 4). Zoospores moved away from the
metabolite less frequently as location from the source increased within the 2,4-DAPG
high treatment (P = 0.0200) (Table 4) (Figure 11 B).
Sampling location did not have a significant effect on zoospore total movement
over a ten second period of time within the control, 2,4-DAPG low, and I3C treatments
(Table 4). There was an effect of location on zoospore total movement within the 2,4DAPG high treatment, where zoospores moved further away from the metabolite at
sampling locations 0-100µm and 200-300µm than zoospores sampled at 500-600µm (P =
0.0001). Locations were pooled for all treatments, including 2,4-DAPG high, since the
overall trend was for the response variables to not vary as a function of location.

42

Table 4. The effect of location on B. dendrobatidis (JEL 310) movement within
treatment comparisons towards and away from the source and total distance a zoospore
moved within a time period.
ANOVA
Movement towards the source
Treatment

n’s

df

F

Sig.

Control

10

27

0.05

0.9540

2,4-DAPG low

10

27

2.57

0.9720

2,4-DAPG high

10

27

7.79

0.0025

I3C

6

15

1.46

0.2707

Movement away from the source
Treatment

n’s

df

F

Sig.

Control

10

27

0.02

0.9777

2,4-DAPG low

10

27

0.86

0.4346

2,4-DAPG high

10

27

4.62

0.0200

I3C

6

15

0.50

0.6202

Total distance a zoospore moved during a 10 sec. period
Treatment

n’s

df

F

Sig.

Control

10

27

0.50

0.6150

2,4-DAPG low

10

27

3.08

0.0645

2,4-DAPG high

10

27

7.79

0.0001

I3C

6

15

1.79

0.2088
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Figure 11. Average B. dendrobatidis (JEL 310) zoospore movement
over two time periods (0 and 6 hours) toward the source (A) and away
from the source (B) for control (n’s = 10), I3C (n’s = 6), 2,4-DAPG
low (n’s = 10), and 2,4-DAPG high (n’s = 10) respectively at each
sampling location. Location only had a significant effect on 2,4-DAPG
high both towards the metabolite (P = 0.0025) and away from the
metabolite (P = 0.0200). Letters above the graphs represent Tukey
groupings for 2,4-DAPG high.

Between treatment comparisons
Movement towards the source
Treatment had a significant effect on zoospore movement towards the source.
Zoospores in the control moved towards the source significantly more than 2,4-DAPG at
low and high treatments (P < 0.0001) (Table 5) (Figure 12A). Both 2,4-DAPG low and
high treatments were grouped together and apart from the control treatment as determined
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by Tukey groupings. There was no significant effect on zoospore movement towards the
source between the control and I3C treatments although there was a trend for lower
number of movements towards the I3C treatment (Table 5).

Movement away from the source
The treatments 2,4-DAPG low, 2,4-DAPG high, and I3C had a higher number of
moves away from the source containing the metabolite relative to the control that
contained no metabolite (Figure 12B). Zoospores moved away from the source that
contained both 2,4-DAPG at low and high treatments more frequently than the control
group (P = 0.0086) (Table 5). Zoospores also moved away from the source that
contained I3C more frequently than the control group (P = 0.0149) (Table 5).
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Table 5. Between treatment comparisons of B. dendrobatidis (JEL 310) movement
towards and away from the source.
ANOVA
Movement towards the source
Treatments

n’s

df

F

Sig.

Control, 2,4DAPG low, &
2,4-DAPG high

30

87

11.16

<0.0001

Control & I3C

30, 18

46

3.18

0.0812

Movement away from the source
Treatments

n’s

df

F

Sig.

Control, 2,4DAPG low, and
2,4-DAPG high

30

87

5.04

0.0086

Control and
I3C

30, 18

46

6.40

0.0149
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Figure 12. Average B. dendrobatidis (JEL 310) zoospore movement over sampling
location and time toward the source (A) and away from the source (B) for control (n =
30), 2,4-DAPG low (n = 30), 2,4-DAPG high (n = 30), and I3C (n = 18) respectively.
Both 2,4-DAPG low and high treatments moved towards the source less than the
control (P < 0.0001) and away from the source more relative to the control (P =
0.0086). Zoospores in the I3C treatment did not move away from the source more
than the control (P = 0.0812), but did move away from the source more relative to the
control (P = 0.0149). Asterisk above points are significantly different from the control
and error bars represent standard error.
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B. dendrobatidis (JEL 423) Zoospore Movement Toward and Away from the Source
B. dendrobatidis (JEL 423) zoospore movement data were only collected for
initial time (t = 0 hours). It was determined from the results using isolate 310 that time
had no effect on zoospore movement either towards or away from the source or on total
zoospore movement for a ten second period of time relative to t = 6 hours. Therefore, t =
6 hours was not sampled.

Within treatment comparisons
Location (0-100µm, 200-300µm, and 500-600µm) had no effect on zoospore
movement towards the source within the control, violacein low, and violacein high
treatments (Table 6). Location also had no effect on zoospore movement away from the
source within the control, violacein low, and violacein high (Table 6). During a period of
ten seconds, location had no effect on total zoospore movement towards or away from the
source within the control, violacein low, and violacein high (Table 6). These data were
then pooled together.
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Table 6. The effect of location on B. dendrobatidis (JEL 423) movement within
treatment comparisons towards and away from the source and total distance a zoospore
moved within a time period.
ANOVA
Movement towards the source
Treatment

n’s

df

F

Sig.

Control

5

12

0.50

0.6196

Violacein low

5

12

1.52

0.2575

Violacein high

5

12

0.25

0.7810

Movement away from the source
Treatment

n’s

df

F

Sig.

Control

5

12

0.30

0.7475

Violacein low

5

12

0.01

0.9867

Violacein high

5

12

2.67

0.1100

Total distance a zoospore moved during a 10 sec. period
Treatment

n’s

df

F

Sig.

Control

5

12

1.32

0.3041

Violacein low

5

12

0.72

0.5075

Violacein high

5

12

2.17

0.1565

Between treatment comparisons
The control and both violacein low and high concentration had approximately
equal movements both towards and away from the source (Table 7) (Figure 13A-B).
Treatment also had no effect on total distance a zoospore moved towards or away from
the source among the control and both violacein low and high treatments (Table 7).
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Table 7. Between treatment comparisons of B. dendrobatidis (JEL 423) movement
towards and away from the source and total movement of a zoospore during a time
period.
ANOVA
Movement towards the source
Treatments

n’s

df

F

Sig.

Control,
violacein low,
& violacein
high

15

42

0.44

0.6470

Movement away from the source
Treatments

n’s

df

F

Sig.

Control,
violacein low,
& violacein
high

15

42

0.71

0.5005

Total distance a zoospore moved during a 10 sec. period
Treatments

n’s

df

F

Sig.

Control,
violacein low,
& violacein
high

15

42

0.07

0.9287
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Figure 13. Treatment had no effect on the number of movements a B. dendrobatidis
(JEL 423) zoospore took either towards (A) the source or away (B) from the source
among the control and both violacein low and high treatments. Letters represent
Tukey groupings and error bars represent standard error.

B. dendrobatidis (JEL 310) Zoospore Activity

Within treatment comparisons
More zoospores were active at t = 0 hours than t = 6 hours within the control (P <
0.0001), 2,4-DAPG low (P < 0.0001), 2,4-DAPG high (P = 0.0003), and I3C (P =
0.0002) treatments (Table 8) (Figure 14A-B and Figure 15A-B). Location (0-100µm and
500-600µm) had no effect on the number of active zoospores within the control, 2,4-
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DAPG at low, and I3C treatments (Table 8). There were more active zoospores at 500600µm than at 0-100µm within the 2,4-DAPG high treatment (P = 0.0005) (Table 8)
(Figure 15B). Locations were pooled for all treatments, including 2,4-DAPG high, since
the overall trend was for the response variables to not vary as a function of location.

Table 8. Effect of time and location on B. dendrobatidis (JEL 310) zoospore activity
within treatments.
ANOVA
Effect of time (t = 0 and t = 6 hours)
Treatment

n’s

df

F

Sig.

Control

10

18

64.21

<0.0001

2,4-DAPG low

10

18

94.85

<0.0001

2,4-DAPG high

10

18

21.52

0.0003

I3C

6

10

40.41

0.0002

Treatment

n’s

df

F

Sig.

Control

10

18

0.18

0.6788

2,4-DAPG low

10

18

1.75

0.2050

2,4-DAPG high

10

18

21.52

0.0005

I3C

6

10

0.05

0.8273

Effect of location

Between treatment comparisons
The control and 2,4-DAPG low treatments had approximately equal number of
active zoospores relative to 2,4-DAPG high treatment that had lower numbers of active
zoospores (P = 0.0005) (Table 9) (Figure 14A-B and Figure 15A). Treatment had no
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effect on the number of active zoospores between the control and I3C treatments (Table
9) (Figure 14A and Figure 15B).

Table 9. Between treatment comparisons of B. dendrobatidis (JEL 310) zoospore
activity.
ANOVA
Treatments

n’s

df

F

Sig.

Control, 2,4DAPG low, &
2,4-DAPG high

20

57

8.89

0.0005

Control & I3C

20, 12

30

0.02

0.8766
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Figure 14. Time had an effect on active zoospores within both the control (n’s = 10)
and 2,4-DAPG low (n’s = 10) (P < 0.0001 and P < 0.0001 respectively) treatments.
The number of active zoospores was approximately equal for both the control and 2,4DAPG low at both time and location.
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Figure 15. Time had an effect on active zoospores within both the 2,4-DAPG high
(n’s = 10) and I3C (n’s = 6) (P = 0.0003 and P = 0.0002 respectively). The number of
active zoospores was less 2,4-DAPG high at both time and location relative to both the
control and 2,4-DAPG low (n’s = 20) (P = 0.0005).

B. dendrobatidis (JEL 423) Zoospore Activity

Within treatment comparisons
Zoospore activity did not change over two times sampled (t = 0 and t = 6 hours)
within the control, violacein low, and violacein high treatments (Table 10). Location had
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no effect on zoospore activity within the control, violacein low, and violacein high
treatments (Table 10).

Table 10. Effect of time and location on B. dendrobatidis (JEL 423) zoospore activity
within treatments.
ANOVA
Effect of time (t = 0 and t = 6 hours)
Treatment

n’s

df

F

Sig.

Control

5

9

0.09

0.7618

Violacein low

5

9

2.12

0.0782

Violacein high

5

9

0.06

0.6244

Treatment

n’s

df

F

Sig.

Control

5

9

0.09

0.7618

Violacein low

5

9

2.12

0.1632

Violacein high

5

9

0.06

0.6244

Effect of location

Between treatment comparisons
B. dendrobatidis (JEL 423) zoospore activity did not differ between the control (n
= 5) and both violacein at low (n = 5) and high (n = 5) concentrations (F = 0.56; DF =
2,12; P = 0.5760).
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Mathematical Models (JEL 310)
The number of movements a zoospore took from the furthest starting position
(D9) for simulations that took between 9-100 movements to reach the source can be seen
in Figure 16. Not all simulations reached the source between 9-100 movements and took
move movements to reach the source. The median number of movements to reach the
source was found for simulations in the control to be 12.1. The median number of
movements in the 2,4-DAPG low and 2,4-DAPG high treatments was 39.8 and 42.2
respectively. The median number of movements to reach the source in the I3C treatment
was 32.2.

Figure 16. The median number of movements a single B. dendrobatidis (JEL
310) zoospore took to reach the source for 500 simulations if released at the
location furthest from the source (D9). Only simulations that reached the
source between 9-100 movements are shown.
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The model to illustrate zoospore dispersal where 200 zoospores are released at D5
results are shown in Figure 17. The weighted average is lower in the control compared to
the other three treatments (2,4-DAPG low, 2,4-DAPG high, and I3C). Zoospores in the
three experimental treatments continue to move away from the source as depicted by the
weighted averages increasing as time steps increase. Zoospores in the control treatments
continue to move closer to the source as depicted by the weighted averages decreasing as
time steps increase.

Figure 17. Average number of B. dendrobatidis (JEL 310) zoospores at
locations in the model at six different time steps (0, 10, 20, 30, 40, 50).
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Mathematical Models (JEL 423)
The number of movements a zoospore took from the furthest starting position
(D9) for simulations that took between 9-100 movements to reach the source can be seen
in Figure 18. Not all simulations reached the source between 9-100 movements and took
move movements to reach the source. The median number of movements simulations
from the control treatment took was 23.4 movements. The median number of movements
from simulations from the violacein low treatment was 54.3. The median number of
movements from the violacein high treatment was 32.2.

Figure 18. The median number of movements a single B. dendrobatidis (JEL 423)
zoospore took to reach the source for 500 simulations if released at the location
furthest from the source (D9). Only simulations that reached the source between 9-100
movements are shown.
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The model to illustrate zoospore dispersal where 200 zoospores are released at D5
results are shown in Figure 19. The weighted average is lower in the control and
violacein high treatments compared to the violacein low treatment. Zoospores in the
control and violacein high treatments continue to move towards the source as time steps
increase. Zoospores in the violacein low treatment moves away from the source as time
steps increase.

Figure 19. Average number of B. dendrobatidis (JEL 423) zoospores at locations in the
model at six different time steps (0, 10, 20, 30, 40, 50).

Discussion
Amphibian populations that co-exist with B. dendrobatidis do so with sub-lethal
infections and several co-existing populations have also been identified with higher
proportions of individuals with anti-B. dendrobatidis skin bacteria (Lam et al. 2010,
Woodhams et al. 2007b). Skin bacteria may drive B. dendrobatidis densities down and
keep densities below a lethality-threshold resulting in sub-lethal infections. There are
three hypothesized mechanisms that skin bacteria may use to drive B. dendrobatidis
densities down: 1) skin bacteria may reduce the number of available attachment sites on
amphibian skin, 2) antifungal metabolites produced by skin bacteria may directly kill B.
dendrobatidis, and 3) skin bacteria may alter B. dendrobatidis zoospore behavior
resulting in chemotaxis away from bacterially-produced antifungal metabolites.
The results show that zoospores have chemotactic behavior in the presence of two
bacterially-produced metabolites (2,4-DAPG and I3C). Zoospores exhibit chemotaxis in
the presence of keratin suggesting that the pathogen has some ability to locate its
amphibian host (Moss et al. 2008). I have now also shown that zoospores show a
behavioral response to antifungal metabolites that are produced by bacteria isolated from
amphibian skin. Zoospores move more frequently away from sources of 2,4-DAPG and
I3C.
These results increase support that amphibian skin bacteria play a role in the
defense against the amphibian disease chytridiomycosis. More research is needed to
determine transmission effects of having different proportions of individuals with anti-B.
dendrobatadis bacteria. Once an effective proportion of individuals needed to have anti-
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B. dendrobatidis to protect a population is found, using bacteria to bio-augment
amphibian populations may be a tool for conservational purposes.

B. dendrobatidis Zoospore Movement Patterns
Both isolates of B. dendrobatidis zoospores (JEL 310 and JEL 423) had similar
behavioral patterns of movement in all treatments. The two most frequent movement
patterns were circular and oscillations either inward or outward. Because zoospores
moved in this way, the method by which I determined differences in the total zoospore
movement either toward or away from the edge of the source (measuring the initial
distance a zoospore was from the edge of the agar source and end point distance after ten
seconds) may not have been an appropriate. Depending on where the zoospore was
during its oscillation, total distance traveled might not reflect the general trend moved
toward or away from a metabolite. Determining where the zoospore is at its closet point
to the edge of the source and at its furthest point at the edge of the source would result in
a better overall measurement of total distance a zoospore moves towards or away from a
metabolite.

B. dendrobatidis Zoospore Activity and Sampling Time
Two sampling times were chosen to be initial time (t = 0 hours) and the time at
which 50% of B. dendrobatidis (JEL 310) zoospores remained active. The data show that
at approximately 6 hours 50% of zoospores from isolate JEL 310 were no longer active.
Inactivity suggests that the zoospores were beginning to settle from absorbing their
flagella to transition into their sporangium life stage. At 24 hours zoosporangium could
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be seen implicating that these zoospores were not dead. These results were different for
isolate 423 where approximately 75% of zoospores were still active at 12 hours. Finally,
Piotrowski et al. (2004) observed that B. dendrobatidis isolate JEL 197 showed
approximately 50% of zoospores were active at 18 hours.
The difference in zoospore activity between isolates may be a result genetic
variation, however recent studies have found that there is little variation found among
isolates (James et al. 2009, Morehouse et al. 2003). Another explanation for the
difference in zoospore activity may be the amount of time an isolate is kept in lab after it
has been isolated from the wild. Voyles et al. (2009) found that pathogenesis of B.
dendrobatidis decreased with the amount of time an isolate was kept in the lab. Isolate
JEL 310 had been kept in lab approximately a year before it had been used for this
experiment. Isolate 423 had only been in the lab for one month before its use and had
just recently been cultured from -800C. Continual making of new weekly stocks of B.
dendrobatidis may select for zoospores that settle more quickly in the broth culture
relative to newly isolated B. dendrobatidis from amphibians. Zoospores that settle and
encyst quickly in broth cultures may have a higher fecundity in lab than in nature.
Zoospores that remain active longer may have a better chance at survival in nature
because it allows them more time to search out for susceptible amphibian hosts.

How Amphibian Skin Bacteria May Ameliorate the Effects of Chytridiomycosis
Previous research has shown that amphibians with anti-B. dendrobatidis bacteria
on their skins suffer less morbidity and mortality when infected with B. dendrobatidis
than amphibians without anti-B. dendrobatidis bacteria (Becker et al. 2009, Harris et al.
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2006, Harris et al. 2009a, Harris et al. 2009b). The mechanism(s) of the benefit(s) from
having anti-B. dendrobatidis bacteria on amphibian skins are not fully known. It is
hypothesized that skin bacteria may compete with B. dendrobatidis zoospores for
attachment sites. As the density of skin bacteria on an amphibian increases, available
attachment sites for B. dendrobatidis zoospores may decrease and may drive the density
of zoospores to stay below the lethal threshold. It is also hypothesized that skin bacteria
that produce antifungal compounds that kill B. dendrobatidis may also drive the density
of zoospores to stay below the lethal threshold by direct mortality. The concentrations of
bacterially-produced metabolites are poorly estimated on amphibian skin (Brucker et al.
2008b), but concentrations are hypothesized to be most likely variable and unevenly
dispersed on amphibian skin due to the different microenvironments on amphibian skin.
It is possible that with large densities of skin bacteria that produce anti-B. dendrobatidis
metabolites there may be large enough concentrations of the metabolites in many areas
dispersed evenly on amphibian skin to cause enough direct mortality of B. dendrobatidis
to drive the density of zoospores below the lethal threshold. An additional hypothesis
may be B. dendrobatidis zoospores avoid bacterially-produced metabolites at low
concentrations and that the zoospores ability to move away from the metabolites is what
drives the zoospore density below lethal threshold.

B. dendrobatidis (JEL 310) Chemotaxis in the Presence of Bacterially-Produced
Metabolites
B. dendrobatidis (JEL 310) show chemotaxis in the presence of 2,4-DAPG at low
and high concentration and I3C at high concentration. Both of these metabolites have
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been shown to be anti-B. dendrobatidis in inhibition assays in vitro. The metabolite 2,4DAPG is a known metabolite produced by several Pseudomonas species (Weller et al.
2007) and was also identified from Lysobacter gummosus isolated from the eastern redbacked salamander, Plethodon cinereus (Brucker et al. 2008a, Harris et al. 2006). Many
different species of Pseudomonas have been isolated from amphibians and have shown
antifungal properties, but metabolites have not been identified (Harris et al. 2006, Lam et
al. 2010, Lauer et al. 2007, Lauer et al. 2008, Woodhams et al. 2007b). The metabolite
I3C was identified from Janthobacterium lividum (Brucker et al. 2008b) and this bacteria
species has been identified on several amphibians (Harris et al. 2006, Lauer et al. 2007,
Lam et al. 2010, Woodhams et al. 2007b). Identification for these metabolites on
amphibian skin has not been researched.
Zoospores move more frequently toward a source containing no metabolite than
from a source containing either 2,4-DAPG at low and high concentration or I3C at high
concentration. Likewise, zoospores also moved more frequently away from a source
containing a metabolite than a source containing no metabolite. These data suggest that
not only do zoospores have chemotaxis in the presence of these metabolites, but also that
overall zoospore movement is away from the metabolites. Additional observations
indicated that zoospores were concentrated at the farthest distance from the metabolite
source, which supports this conclusion.
It is hypothesized that metabolites would form a concentration gradient from the
source containing the metabolite and the furthest location away from the metabolite in
solution. However, location had no effect on zoospore movement either towards the
metabolite or away from the metabolite for the control, 2,4-DAPG low and I3C high
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treatments. This may be due to the small volume of Provosoli that each chamber held. In
the future concentration gradients should be measured. If the chambers do not represent
a concentration gradient then it is likely that if the chambers were made to be longer and
measurements taken further from the source then the effect of location may have be seen.
However, casual observations showed that zoospore density was highest at the far edge of
the chamber away from the metabolite. In addition, it is likely that a gradient was present
at t = 0 and behavior was the same six hours later. This observation also suggests a
gradient established. These observations, along with the bulk of the chemotaxis data,
suggest that a concentration gradient was established.
The metabolite 2,4-DAPG at high concentration did show an effect of location on
zoospore movement both towards the metabolite and away from the metabolite.
Zoospores moved towards 2,4-DAPG high more frequently further away from the
metabolite and moved less frequently away from the metabolite as distance increased. It
is possible that at the high concentration of 2,4-DAPG there may have been deleterious
effects on the zoospores that cause their movement to be erratic.

B. dendrobatidis (JEL 423) Showed No Chemotaxis in the Presence of BacteriallyProduced Violacein
B. dendrobatidis isolate JEL 423 showed no chemotaxis in the presence of
violacein at either low or high concentration. There are several explanations for this that
need further investigation. One explanation may be that there is variation between the
two isolates (JEL 310 and 423) either due to genetic variation or due to variation in their
pathogenesis and behavior based on number of generations in the laboratory. If JEL 423
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has a higher pathogenesis than JEL 310 it could explain why JEL 423 showed no
chemotaxis in the presence of violacein. Behavior can be a part of determining the
pathogenesis for an organism. Perhaps one factor making isolates highly pathogenic is
due to the isolates ability to withstand bacterially-produced metabolites such as violacein.
Another explanation for why JEL 423 showed no chemotaxis in the presence of violacein
may be due to the metabolites insolubility in Provosoli medium. Repeating this
experiment again with 1% dimethyl sulfoxide (DMSO) in addition to the Provosoli
medium may allow for the metabolite to form a concentration gradient and may change
the chemotaxis of zoospores in the presence of violacein. However, this brings about the
question of how likely is this in nature? If violacein is insoluble in Provosoli medium
than does it form a concentration gradient in the mucus layer it is found it? One
possibility is that Janthinobacterium lividum that produces violacein (Brucker et al.
2008b) also secretes a molecule that makes the violacein soluble. More research is
necessary to fully understand the mechanism(s) that insoluble bacterially-produced
metabolites use to ameliorate chytridiomycosis.

B. dendrobatidis (JEL 310) Zoospore Activity in the Presence of Bacterially-Produced
Metabolites
There were more active zoospores at t = 0 hours than at t = 6 hours within the
control and all three of the treatments (2,4-DAPG low, 2,4-DAPG high, and I3C high).
This is not surprising considering that 50% of the zoospores (JEL 310) are no longer
active at 6 hours and this likely contributes to the effect of time. Location had no effect
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on active zoospores for within all treatments with the exception of 2,4-DAPG at high
concentration.
The control and 2,4-DAPG treatments had similar numbers of active zoospores
than the 2,4-DAPG high treatment. This result may have been due to direct mortality of a
proportion of zoospores exposed to a high concentration of 2,4-DAPG. There was no
effect of treatment on the number of active zoospores at two locations sampled between
the control and I3C at high concentration.

B. dendrobatidis (JEL 423) Zoospore Activity in the Presence of Violacein
There was no significant effect of treatment on B. dendrobatidis (JEL 423)
zoospore activity between the control and both violacein at low and high concentrations.
Explanations for this are similar to the explanations to explain why there were no effects
of violacein on zoospore movement towards or away from the source.

B. dendrobatidis (JEL 310) Zoospores Take Longer to Reach the Source and Are Less
Likely to Distribute on The Source in the Presence of Bacterially-Produced Metabolites
Using parameters estimated from data collected on zoospore movement, it was
observed that when a single zoospore was released from the middle of the model (D5) it
reached the source more quickly in the control than the three treatments (2,4-DAPG low,
2,4-DAPG high, and I3C). This suggests that if zoospores were released into the
environment they would reach amphibians without bacterially-produced metabolites
more quickly than amphibians with bacterially-produced metabolites.
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The model to illustrate the transmission of 200 zoospores that are released in the
furthest location of the model (D9) shows that as time increases zoospores move in
locations further away from the source in all experimental treatments. Zoospores in the
control treatment move towards locations closer to the source as time increases. This
suggests that if zoospores are released into the environment that amphibians that have
bacterially-produced metabolites on their skins would have a lower proportion of
zoospores that infect the amphibian than those that do not have bacterially-produced
metabolites on their skins.
This model also illustrates that zoospores released from sporangia located on frog
skin that also have antifungal metabolites will leave the frog skin and this may drive
zoospore density to remain below the lethal-threshold and also increase transmission to
susceptible amphibians. In the presence of no metabolite, zoospores released from
sporangia located on amphibian skin are more likely to remain on frog skin and reinfecting the amphibian. This could drive exponential growth of zoospores on amphibian
skin and quickly surpass lethal-threshold.

B. dendrobatidis (JEL 423) Zoospores Are Equally Likely to Reach the Source and
Are Less Likely to Distribute on the Source in the Presence of Violacein at Low
Concentrations
The model predicts that more zoospores will take longer to reach the source in the
violacein low treatment compared to the control and violacein high treatment. This
suggests that if an amphibian has low concentrations of violacein on its skin, zoospores
will take longer to reach the amphibian.
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The model to illustrate the transmission of 200 zoospores that are released in the
middle of the model (D5) shows that as time increases zoospores move in locations
further away from the source in the violacein low treatment. Zoospores in the control
and violacein high treatments first move away from the source and then gradually move
closer towards the source. This suggests that if zoospores are released into the
environment that amphibians that have violacein in low concentrations on their skins
would have a lower proportion of zoospores that infect the amphibian than those that do
not have violacein or have violacein at high concentrations on their skins.

Conclusion
The results of this study show that B. dendrobatidis zoospores show chemotaxis
in the presence of two bacterially-produced metabolites and that zoospores are less likely
to distribute onto a source containing metabolites than a source that does not have
metabolites. Chemotaxis of zoospores in the presence of metabolites may be a
mechanism driving and maintaining zoospore density on frog skin to stay below the
lethal threshold. Skin bacteria that produce anti-B. dendrobatidis metabolites may
ameliorate the effects of chytridiomycosis on amphibians that host them. These
amphibians may also co-exist with B. dendrobatidis even if sporangia are found on their
skins if sporangia are found at very low numbers.
Understanding all of the components of the amphibian innate immune system and
defenses and how the interactions between the components protect amphibians from
diseases such as chytridiomycosis needs more research. Future research should focus on
synergistic or antagonistic relationships between amphibian skin bacteria and amphibian
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produced AMPs. Identifying population density and distributions of skin bacteria on
amphibian skin in different microenvironments is needed to infer how effective
bacterially defenses are. There is need to understand how zoospores move in pond water
compared to the mucus on the amphibian skin. Also needed is a determination of the
most effective concentration of metabolites needed to produce the maximal effects of bioaugmentation. Results of I3C and violacein at high concentration suggest that these
metabolites may be more effective at lower concentrations to encourage the smallest
proportion of zoospores to disperse to frog skin. For conservation purposes, bioaugmentation of amphibian skin with too much bacteria may be costly for the host to
maintain or may cause disease as many commensal bacteria are shown to do at high
densities. However, bio-augmentation of amphibian skin bacteria with an appropriate
number of bacteria may have the desired effects of ameliorating chytridiomycosis
without any cost to the amphibian.
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